Healthcare provider profile · identity verified

Alec Dedavets, M.D.

Internal Medicine · YUBA CITY, CA · NPI 1073800066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	717	249
Amlodipine Besylate	Amlodipine Besylate	461	158
Levothyroxine Sodium	Levothyroxine Sodium	404	126
Losartan Potassium	Losartan Potassium	401	144
Lisinopril	Lisinopril	334	116
Atenolol	Atenolol	242	79
Tamsulosin Hcl	Tamsulosin Hcl	242	92
Trazodone Hcl	Trazodone Hcl	225	72
Hydrochlorothiazide	Hydrochlorothiazide	203	70
Simvastatin	Simvastatin	201	65
Gabapentin	Gabapentin	197	91
Furosemide	Furosemide	193	77
Albuterol Sulfate Hfa	Albuterol Sulfate	188	89
Metformin Hcl Er	Metformin Hcl	188	75
Pantoprazole Sodium	Pantoprazole Sodium	187	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	186	43
Metoprolol Succinate	Metoprolol Succinate	169	64
Metoprolol Tartrate	Metoprolol Tartrate	167	59
Fluticasone Propionate	Fluticasone Propionate	161	53
Meloxicam	Meloxicam	153	68
Omeprazole	Omeprazole	140	55
Allopurinol	Allopurinol	138	48
Famotidine	Famotidine	136	52
Potassium Chloride	Potassium Chloride	133	54
Alvesco	Ciclesonide	131	51
Ibuprofen	Ibuprofen	128	57
Rosuvastatin Calcium	Rosuvastatin Calcium	118	43
Prednisone	Prednisone	101	61
Alendronate Sodium	Alendronate Sodium	100	30
Tramadol Hcl	Tramadol Hcl	95	24
Metformin Hcl	Metformin Hcl	90	32
Carvedilol	Carvedilol	87	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	37
Ozempic	Semaglutide	84	23
Sertraline Hcl	Sertraline Hcl	84	27
Wixela Inhub	Fluticasone Propion/Salmeterol	83	25
Jardiance	Empagliflozin	80	36
Glimepiride	Glimepiride	79	27
Alprazolam	Alprazolam	78	14
Hydralazine Hcl	Hydralazine Hcl	77	25
Terazosin Hcl	Terazosin Hcl	76	24
Tizanidine Hcl	Tizanidine Hcl	76	27
Escitalopram Oxalate	Escitalopram Oxalate	74	24
Lorazepam	Lorazepam	73	21
Duloxetine Hcl	Duloxetine Hcl	71	30
Pradaxa	Dabigatran Etexilate Mesylate	70	22
Temazepam	Temazepam	68	14
Montelukast Sodium	Montelukast Sodium	67	24
Triamcinolone Acetonide	Triamcinolone Acetonide	66	44
Mirtazapine	Mirtazapine	65	21
Glipizide	Glipizide	62	22
Donepezil Hcl	Donepezil Hcl	61	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	21
Fluoxetine Hcl	Fluoxetine Hcl	57	19
Finasteride	Finasteride	55	18
Trospium Chloride	Trospium Chloride	55	20
Lovastatin	Lovastatin	52	19
Citalopram Hbr	Citalopram Hydrobromide	51	20
Propranolol Hcl	Propranolol Hcl	51	15
Azelastine Hcl	Azelastine Hcl	50	19
Buspirone Hcl	Buspirone Hcl	48	suppressed
Clobetasol Propionate	Clobetasol Propionate	47	24
Acyclovir	Acyclovir	46	20
Spironolactone	Spironolactone	46	18
Spiriva Respimat	Tiotropium Bromide	44	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	29
Warfarin Sodium	Warfarin Sodium	42	17
Bupropion Xl	Bupropion Hcl	41	16
Baclofen	Baclofen	40	suppressed
Ketoconazole	Ketoconazole	40	16
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	11
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	35	15
Bisoprolol Fumarate	Bisoprolol Fumarate	34	12
Clonazepam	Clonazepam	34	suppressed
Pregabalin	Pregabalin	33	12
Ondansetron Odt	Ondansetron	32	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Lactulose	Lactulose	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	27	11
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Naproxen	Naproxen	26	17
Estradiol	Estradiol	25	11
Fluocinonide	Fluocinonide	25	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	13
Amoxicillin	Amoxicillin	24	12
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	11
Mupirocin	Mupirocin	24	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Metronidazole	Metronidazole	23	13
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	12
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Cefadroxil	Cefadroxil	20	20
Diltiazem Hcl	Diltiazem Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Hydrocortisone	Hydrocortisone	20	14
Tadalafil	Tadalafil	20	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	suppressed
Digoxin	Digoxin	19	suppressed
Eliquis	Apixaban	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Humulin N	Insulin Nph Human Isophane	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Naratriptan Hcl	Naratriptan Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Colchicine	Colchicine	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Azithromycin	Azithromycin	12	11
Cartia Xt	Diltiazem Hcl	12	suppressed
Victoza 2-Pak	Liraglutide	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Myrbetriq	Mirabegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error